These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7530564)

  • 21. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
    Zeng L; Rowland RG; Lele SM; Kyprianou N
    Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of acidic and basic fibroblast growth factors in benign prostatic hyperplasia identified by immunohistochemistry.
    Deshmukh N; Scotson J; Dodson AR; Smith PH; Ke Y; Foster CS
    Br J Urol; 1997 Dec; 80(6):869-74. PubMed ID: 9439399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia.
    Jackson MW; Bentel JM; Tilley WD
    J Urol; 1997 Jun; 157(6):2323-8. PubMed ID: 9146664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate.
    Sherwood ER; Lee C
    World J Urol; 1995; 13(5):290-6. PubMed ID: 8581000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of epidermal growth factor receptor mRNA levels in normal, benign hyperplastic and carcinomatous prostate.
    Kumar VL; Majumder PK; Gujral S; Kumar V
    Cancer Lett; 1998 Dec; 134(2):177-80. PubMed ID: 10025878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines.
    Dahiya R; Lee C; Haughney PC; Chui R; Ho R; Deng G
    Urology; 1996 Dec; 48(6):963-70. PubMed ID: 8973690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The morphogenesis of cancer of the prostate (immunohistochemical research)].
    Vorobĭova LR
    Lik Sprava; 1998 May; (3):87-90. PubMed ID: 9695575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis.
    Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF
    Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical localization of transforming growth factor-alpha, epidermal growth factor receptor and c-erbB-2 protein in hyperplastic human prostates.
    Giri DK; Pal R; Wadhwa SN; Talwar GP
    Carcinogenesis; 1995 Apr; 16(4):729-33. PubMed ID: 7537180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumors.
    Harper ME; Goddard L; Glynne-Jones E; Wilson DW; Price-Thomas M; Peeling WB; Griffiths K
    Prostate; 1993; 23(1):9-23. PubMed ID: 7687782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of transforming growth factor alpha (TGFalpha) and epidermal growth factor receptor (EGFR) in sex hormone-induced prostatic dysplasia and the growth of an androgen-independent transplantable carcinoma of the prostate.
    Kaplan PJ; Leav I; Greenwood J; Kwan PW; Ho SM
    Carcinogenesis; 1996 Dec; 17(12):2571-9. PubMed ID: 9006091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
    J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyaluronan-mediated motility receptor (RHAMM) immunohistochemical expression and androgen deprivation in normal peritumoral, hyperplasic and neoplastic prostate tissue.
    Korkes F; de Castro MG; de Cassio Zequi S; Nardi L; Del Giglio A; de Lima Pompeo AC
    BJU Int; 2014 May; 113(5):822-9. PubMed ID: 24053431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer.
    Häussler O; Epstein JI; Amin MB; Heitz PU; Hailemariam S
    Hum Pathol; 1999 Sep; 30(9):1077-86. PubMed ID: 10492043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor beta 1 expression in benign and malignant prostatic tumors.
    Glynne-Jones E; Harper ME; Goddard L; Eaton CL; Matthews PN; Griffiths K
    Prostate; 1994 Oct; 25(4):210-8. PubMed ID: 7521962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of basic fibroblast growth factor and its receptors FGFR1 and FGFR2 in human benign prostatic hyperplasia treated with finasteride.
    Sáez C; González-Baena AC; Japón MA; Giráldez J; Segura DI; Rodríguez-Vallejo JM; González-Esteban J; Miranda G; Torrubia F
    Prostate; 1999 Jul; 40(2):83-8. PubMed ID: 10386468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms.
    Scher HI; Sarkis A; Reuter V; Cohen D; Netto G; Petrylak D; Lianes P; Fuks Z; Mendelsohn J; Cordon-Cardo C
    Clin Cancer Res; 1995 May; 1(5):545-50. PubMed ID: 9816014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.
    Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE
    J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels.
    Yang Y; Chisholm GD; Habib FK
    Br J Cancer; 1993 Jan; 67(1):152-5. PubMed ID: 7678977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization of annexins I, II, IV and VII in whole prostate sections from radical prostatectomy patients.
    Lehnigk U; Zimmermann U; Woenckhaus C; Giebel J
    Histol Histopathol; 2005 Jul; 20(3):673-80. PubMed ID: 15944914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.